JP2021502828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502828A5 JP2021502828A5 JP2020544386A JP2020544386A JP2021502828A5 JP 2021502828 A5 JP2021502828 A5 JP 2021502828A5 JP 2020544386 A JP2020544386 A JP 2020544386A JP 2020544386 A JP2020544386 A JP 2020544386A JP 2021502828 A5 JP2021502828 A5 JP 2021502828A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cells
- promoter
- item
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762585833P | 2017-11-14 | 2017-11-14 | |
| US62/585,833 | 2017-11-14 | ||
| PCT/US2018/060992 WO2019099479A1 (en) | 2017-11-14 | 2018-11-14 | Il-33 secreting immunoresponsive cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502828A JP2021502828A (ja) | 2021-02-04 |
| JP2021502828A5 true JP2021502828A5 (https=) | 2021-12-23 |
Family
ID=66539902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544386A Pending JP2021502828A (ja) | 2017-11-14 | 2018-11-14 | Ｉｌ−３３を分泌する免疫応答性細胞およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200399598A1 (https=) |
| EP (1) | EP3710470A4 (https=) |
| JP (1) | JP2021502828A (https=) |
| CN (1) | CN111601817A (https=) |
| AU (2) | AU2018367449B2 (https=) |
| CA (1) | CA3082560A1 (https=) |
| WO (1) | WO2019099479A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114934071B (zh) * | 2021-04-30 | 2023-10-17 | 四川大学华西医院 | 一种表达免疫调节因子的car载体及其应用 |
| JP2024526090A (ja) * | 2021-06-15 | 2024-07-17 | アロジーン セラピューティクス，インコーポレイテッド | 同種ｃａｒ ｔ細胞の持続性を延長するための宿主ｃｄ７０＋アロ反応性細胞の選択的標的化 |
| GB202109807D0 (en) * | 2021-07-07 | 2021-08-18 | Ucl Business Ltd | Cell |
| CN116396395A (zh) * | 2021-12-28 | 2023-07-07 | 广州达安基因股份有限公司 | 人转铁融合蛋白及其制备方法 |
| CN116138212B (zh) * | 2023-01-11 | 2024-03-05 | 江苏省中医院 | 一种制备细胞因子释放综合征小鼠模型的方法及应用 |
| CN119055748B (zh) * | 2023-05-30 | 2026-03-17 | 南方科技大学 | Il-33在制备调节ilc2细胞比例和数量的药物中的应用 |
| CN120775059A (zh) * | 2024-04-01 | 2025-10-14 | 常州市第一人民医院 | 一种il-33修饰的嵌合抗原受体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160186208A1 (en) * | 2013-04-16 | 2016-06-30 | Whitehead Institute For Biomedical Research | Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal |
| RU2749113C2 (ru) * | 2015-04-22 | 2021-06-04 | Куревак Аг | Содержащая рнк композиция для лечения опухолевых заболеваний |
| WO2017004153A1 (en) * | 2015-06-29 | 2017-01-05 | The Broad Institute Inc. | Tumor and microenvironment gene expression, compositions of matter and methods of use thereof |
| US12241053B2 (en) * | 2015-10-09 | 2025-03-04 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
| CN109069539A (zh) * | 2016-02-18 | 2018-12-21 | 恩立夫克治疗有限责任公司 | 用于癌症治疗的联合免疫疗法和细胞因子控制疗法 |
| CN107058234B (zh) * | 2017-05-12 | 2019-09-13 | 常州市第一人民医院 | Car.il-33-t及其制备与应用 |
-
2018
- 2018-11-14 AU AU2018367449A patent/AU2018367449B2/en active Active
- 2018-11-14 EP EP18879753.4A patent/EP3710470A4/en not_active Withdrawn
- 2018-11-14 CA CA3082560A patent/CA3082560A1/en active Pending
- 2018-11-14 CN CN201880086444.8A patent/CN111601817A/zh active Pending
- 2018-11-14 WO PCT/US2018/060992 patent/WO2019099479A1/en not_active Ceased
- 2018-11-14 JP JP2020544386A patent/JP2021502828A/ja active Pending
-
2020
- 2020-05-13 US US15/930,947 patent/US20200399598A1/en not_active Abandoned
-
2023
- 2023-03-23 US US18/188,795 patent/US20230242879A1/en active Pending
-
2024
- 2024-09-10 AU AU2024219552A patent/AU2024219552A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502829A5 (https=) | ||
| JP2021502828A5 (https=) | ||
| JP7755890B2 (ja) | Ｃａｒ発現ベクター及びｃａｒ発現ｔ細胞 | |
| US20240059754A1 (en) | Chimeric antigen receptors and enhancement of anti-tumor activity | |
| JP7462782B2 (ja) | 改変免疫細胞とその使用 | |
| US12410248B2 (en) | Chimeric antigen receptor and its use | |
| JP2021513347A5 (https=) | ||
| JP2016508728A5 (https=) | ||
| IL314563A (en) | Non-HLA-restricted T-cell receptors and their uses | |
| CN109689694B (zh) | 与其受体IL-2Rβ结合的IL2作为用来增强自然杀伤细胞和调节性T细胞活性的平台 | |
| JPWO2019157454A5 (https=) | ||
| RU2015140811A (ru) | Композиции и способы иммунотерапии | |
| JP2017523784A5 (https=) | ||
| JPWO2021071962A5 (https=) | ||
| EP3710470A1 (en) | Il-33 secreting immunoresponsive cells and uses thereof | |
| US20230398216A1 (en) | Chimeric activation receptors | |
| JPWO2020210398A5 (https=) | ||
| Heiblig et al. | Adoptive immunotherapy for acute leukemia: new insights in chimeric antigen receptors | |
| A Baeuerle et al. | Clinical experience with gene therapy and bispecific antibodies for T cell-based therapy of cancer | |
| CN115873801A (zh) | 工程化免疫细胞及其用途 | |
| JPWO2022098925A5 (https=) | ||
| KR20250089551A (ko) | 입양 세포 요법과 표적 면역사이토카인을 조합하여 이용한 암 치료 방법 | |
| CN115725504A (zh) | 工程化免疫细胞及其用途 | |
| JPWO2022159791A5 (https=) | ||
| CN116103239A (zh) | 工程化免疫细胞及其用途 |